Dangerous Drug: Phentolamine Mesylate



Dangerous Drug: Phentolamine Mesylate





(fen tole’ a meen)

OraVerse, Rogitine (CAN)

PREGNANCY CATEGORY C


Drug Classes

Alpha-adrenergic blocker

Diagnostic agent


Therapeutic Actions

Competitively blocks postsynaptic alpha1-adrenergic receptors, decreasing sympathetic tone on the vasculature, dilating blood vessels, and lowering arterial BP (no longer used to treat essential hypertension because it also blocks presynaptic alpha2-adrenergic receptors that are believed to mediate a feedback inhibition of further norepinephrine release; this accentuates the reflex tachycardia caused by the lowering of BP); use of phentolamine injection as a test for pheochromocytoma depends on the premise that a greater BP reduction will occur with pheochromocytoma than with other etiologies of hypertension.


Indications



  • Pheochromocytoma: Prevention or control of hypertensive episodes that may result from stress or manipulation during preoperative preparation and surgical excision


  • Pharmacologic test for pheochromocytoma (urinary assays of catecholamines, other biochemical tests have largely supplanted the phentolamine test)


  • Prevention and treatment of dermal necrosis and sloughing following IV administration or extravasation of norepinephrine or dopamine


  • Reversal of soft-tissue anesthesia (OraVerse)


  • Unlabeled use: Treatment of hypertensive crises secondary to interactions between MAOIs and sympathomimetic amines, or secondary to rebound hypertension on withdrawal of clonidine, propranolol, or other antihypertensives



Available Forms

Injection—0.4 mg/1.7 mL, 5 mg/mL


Dosages

Adults

Jul 21, 2016 | Posted by in NURSING | Comments Off on Dangerous Drug: Phentolamine Mesylate

Full access? Get Clinical Tree

Get Clinical Tree app for offline access